Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismail Celik

Showing results (51-60 of 188) with videos related to

Pageof 19
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
N-[(2S)-2-(4-Bromo-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamideMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-(9-Anthr-yl)-1-(3-bromo-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-oneIsmail Celik, Mehmet Akkurt, Aliasghar Jarrahpour, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 26, 2014
1-[3-(Morpholin-4-yl)prop-yl]-4-(3-nitro-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-oneIsmail Celik, Mehmet Akkurt, Aliasghar Jarrahpour, et al.
Structural Chemistry|February 2, 2022
A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from <i>Tridax procumbens</i> as anticancer drug by in-silico approachShradha Lakhera, Meenakshi Rana, Kamal Devlal, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
N-[5-Methyl-2-(2-nitro-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide monohydrateMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-Fluoro-N'-[(E)-4-methoxy-benzyl-idene]-3-phenyl-1H-indole-2-carbohydrazideMehmet Akkurt, Ismail Celik, Gökçe Cihan, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
N-[2-(4-Chloro-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamideMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Cancer Investigation|May 25, 2002
Dihydropyrimidine dehydrogenase enzyme deficiency: clinical and genetic assessment of prevalence in Turkish cancer patientsIsmail Celik, Ayşe Kars, Dicle Guc, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1-Benzyl-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium chloride monohydrateMehmet Akkurt, Ismail Celik, Hasan Küçükbay, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-{3-[Hydr-oxy(phen-yl)meth-yl]-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-4-yl}benzene-sulfonamideMehmet Akkurt, Ismail Celik, Gökçe Cihan, et al.
Pageof 19

Showing results (51-60 of 188) with videos related to

Sort By:
Pageof 19
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
N-[(2S)-2-(4-Bromo-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamideMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-(9-Anthr-yl)-1-(3-bromo-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-oneIsmail Celik, Mehmet Akkurt, Aliasghar Jarrahpour, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 26, 2014
1-[3-(Morpholin-4-yl)prop-yl]-4-(3-nitro-phen-yl)spiro-[azetidine-3,9'-xanthen]-2-oneIsmail Celik, Mehmet Akkurt, Aliasghar Jarrahpour, et al.
Structural Chemistry|February 2, 2022
A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from <i>Tridax procumbens</i> as anticancer drug by in-silico approachShradha Lakhera, Meenakshi Rana, Kamal Devlal, et al.
Acta Crystallographica. Section E, Structure Reports Online|April 28, 2011
N-[5-Methyl-2-(2-nitro-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide monohydrateMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
5-Fluoro-N'-[(E)-4-methoxy-benzyl-idene]-3-phenyl-1H-indole-2-carbohydrazideMehmet Akkurt, Ismail Celik, Gökçe Cihan, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
N-[2-(4-Chloro-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamideMehmet Akkurt, Ismail Celik, Hale Demir, et al.
Cancer Investigation|May 25, 2002
Dihydropyrimidine dehydrogenase enzyme deficiency: clinical and genetic assessment of prevalence in Turkish cancer patientsIsmail Celik, Ayşe Kars, Dicle Guc, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1-Benzyl-3-[(trimethyl-sil-yl)meth-yl]benzimidazolium chloride monohydrateMehmet Akkurt, Ismail Celik, Hasan Küçükbay, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
4-{3-[Hydr-oxy(phen-yl)meth-yl]-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-4-yl}benzene-sulfonamideMehmet Akkurt, Ismail Celik, Gökçe Cihan, et al.
Pageof 19